Share chart Qualigen Therapeutics, Inc.
Extended chart
Simple chart
About Qualigen Therapeutics, Inc.
Qualigen, Inc., биотехнологическая компания, разрабатывает новые терапевтические продукты для лечения рака и инфекционных заболеваний. more detailsIPO date | 2015-06-24 |
---|---|
ISIN | US74754R1032 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | https://www.qualigeninc.com |
Цена ао | 3.36 |
Change price per day: | -1.64% (3.05) |
---|---|
Change price per week: | -4.15% (3.13) |
Change price per month: | -0.3322% (3.01) |
Change price per 3 month: | -29.91% (4.28) |
Change price per half year: | -64.37% (8.42) |
Change price per year: | -81.93% (16.6) |
Change price per 3 year: | +406.76% (0.592) |
Change price per 5 year: | +920.41% (0.294) |
Change price per year to date: | -29.08% (4.23) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Citadel Advisors Llc | 57 | 0.91 |
Renaissance Technologies, LLC | 43 | 0.68 |
Geode Capital Management, LLC | 42 | 0.66 |
Virtu Financial LLC | 28 | 0.44 |
Blackrock Inc. | 26 | 0.41 |
Vanguard Group Inc | 23 | 0.36 |
HRT Financial LP | 13 | 0.2 |
Northern Trust Corporation | 12 | 0.19 |
XTX Topco Ltd | 11 | 0.17 |
State Street Corporation | 11 | 0.17 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Michael S. Poirier | President, COO, CEO & Chairman | 583.18k | 1956 (69 years) |
Mr. Christopher L. Lotz | VP of Finance, CFO & Corporate Secretary | 578.55k | 1965 (60 years) |
Address: United States, Carlsbad. CA, 2042 Corte Del Nogal - open in Google maps, open in Yandex maps
Website: https://www.qualigeninc.com
Website: https://www.qualigeninc.com